Modifies provisions relating to advanced practice registered nurses
Impact
The proposed changes in HB 1875 are significant as they will expand the ability of APRNs to prescribe a wider range of controlled substances, potentially improving access to healthcare services, particularly for patients requiring ongoing treatment for conditions that necessitate these medications. Importantly, the bill restricts certain prescriptions, limiting Schedule II medications to those containing hydrocodone and making provisions for hospice care. This could lead to improved patient care but also raises concerns regarding the safety and oversight of prescribing practices among APRNs.
Summary
House Bill 1875 aims to modify existing provisions relating to advanced practice registered nurses (APRNs) in Missouri by addressing their prescriptive authority and the framework for collaborative practice arrangements with physicians. The bill specifically repeals certain sections of state law and replaces them with new regulations that are intended to clarify the roles and responsibilities of APRNs when prescribing controlled substances, particularly those in Schedules II to V. The bill emphasizes that prescriptive authority for APRNs must be delegated through a collaborative practice arrangement with a physician, outlining specific requirements for such agreements.
Contention
There may be contention surrounding the expansion of APRN authority as traditional physician groups have historically raised concerns about the adequacy of training and supervision of APRNs in prescribing medications, particularly controlled substances. Supporters of the bill argue that it addresses critical gaps in healthcare delivery, especially in rural areas where physician availability may be limited. Critics might contend that increasing APRN prescriptive authority could lead to risks if not adequately monitored, necessitating a careful examination of the regulatory frameworks to ensure patient safety is prioritized.